BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Barry Myers will be speaking on a panel discussing financing mechanisms for emerging companies at the Life Sciences Summit 2011 in New York on November 16.
News | 11. 11. 2011
